Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoproliferative Disorders × Brentuximab Vedotin × 30 days × Clear all

Sponsor

Conditions

Hodgkin Disease 2 Squamous Cell Carcinoma of Head and Neck 1 Neoplasms 1 Melanoma 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Carcinoma, Non-Small-Cell Lung 1 Ann Arbor Stage IIB Hodgkin Lymphoma 1

Interventions

Cyclophosphamide 2 trametinib 1 liposomal doxorubicin 1 fludarabine phosphate 1 fludarabine 1 dabrafenib 1 Zidovudine 1 Whole-Body Irradiation 1 Vincristine 1 Valganciclovir 1 Tacrolimus 1 Sirolimus 1 Rituximab 1 Prednisone 1 Peripheral Blood Stem Cell Transplantation 1 Patient Reported Outcome Measures 1 Nivolumab 1 Mycophenolic Acid 1 Mesna 1 Melphalan 1 Interferon-alpha 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Etoposide 1 Doxorubicin 1 Busulfan 1 Bortezomib 1 Bone Marrow Transplantation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡